MangoRx vs Novi: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Novi beats MangoRx overall, scoring 7.8/10 vs 7.5/10. Novi is more affordable at $133/mo vs $299/mo. Choose MangoRx for needle-phobic users who want oral-only glp-1 tablets from a . Choose Novi for cash-pay patients who want compounded semaglutide or tirzepa.
A side-by-side look at MangoRx and Novi to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
MangoRx
#26 of 53Multi-service telehealth platform offering compounded GLP-1 alongside other health services.
Visit MangoRxNovi
#12 of 53Telehealth platform for compounded semaglutide and tirzepatide with month-to-month billing, six named clinicians on staff, and a 3-minute pre-approval quiz. Novi emphasizes 'all-in transparent' pricing, medication, supplies, unlimited clinician check-ins, dose adjustments, and weight-loss coaching are bundled with no add-on fees. Standard pricing is $174/mo semaglutide and $283/mo tirzepatide; promotional pricing on the offer landing drops to $99-$133/mo semaglutide and $149-$166/mo tirzepatide with $200 off advertised.
Visit Novi| Feature | MangoRx | Novi |
|---|---|---|
| Our Score | 7.5/10 | 7.8/10 |
| Starting Price | $299/mo | $133/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Needle-phobic users who want oral-only GLP-1 tablets from a publicly traded company | Cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer |
| Watch out for | Oral semaglutide at $299/mo runs 2-3x injectable alternatives ($99-149/mo). The premium only makes sense if needles are a hard no for you. | Compounded-only, no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats |
| Ranking | #26 | #12 |
| Get started | Visit MangoRx | Visit Novi |
Pros & Cons Compared
MangoRx
Pros
- +Oral dissolving tablets exclusively, zero injections for any GLP-1 option
- +Publicly traded on NASDAQ (MGRX), SEC-required financial transparency that private competitors can't match
- +Semaglutide tablet includes Vitamin B6 to help reduce nausea during treatment
- +Free 100% online consultation with no video call required
Cons
- −Oral semaglutide at $299/mo runs 2-3x injectable alternatives ($99-149/mo). The premium only makes sense if needles are a hard no for you.
- −Early-stage public company with limited revenue; the same SEC filings that provide transparency also show the financial uncertainty reflected in the stock.
- −Oral tablets are the only format, with no injectable option if you want higher bioavailability. If you may switch to injections later, pick a platform that carries both.
Novi
Pros
- +Six disclosed clinicians on staff, Daniel Funsch MD, Michael Wasef MD, Takashi Nakamura MD plus three nurse practitioners (Hastings NP, Clements NP, Vergara DNP), more named providers than most compounded-only platforms publish
- +Month-to-month billing with no minimum commitment, cancel before any renewal date with no early-termination penalty
- +Aggressive promotional pricing on the offer landing, $99-$133/mo compounded semaglutide and $149-$166/mo compounded tirzepatide with a $200 OFF intro discount
- +Unlimited clinician check-ins, dose adjustments, and weight-loss coaching included at no additional cost
- +Free 2-day shipping; same active ingredients as Wegovy/Ozempic and Mounjaro/Zepbound (semaglutide and tirzepatide respectively)
- +100,000+ patients claimed and editorial coverage in Bloomberg, Forbes, and WebMD provide third-party signal
Cons
- −Compounded-only, no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats
- −Founding year, headquarters city, and corporate ownership are not publicly disclosed
- −Promotional $99-$133 pricing applies to the introductory offer landing only, standard rate after any qualifying intro period is $174-$283/mo (verify the renewal rate before enrolling)
- −Once medication is dispensed/shipped, prescriptions cannot be returned or refunded, typical for compounded telehealth but worth understanding
- −Lab requirements before prescribing are not disclosed on public pages, unclear whether baseline bloodwork is required
- −Multiple landing pages (offer-v4, offer-v6-low) show different headline prices, which can create pricing confusion before checkout
Our Verdict
Novi edges out MangoRx with a score of 7.8/10 vs 7.5/10. If budget is your priority, Novi starts at $133/mo compared to MangoRx's $299/mo. Choose MangoRx if you want: needle-phobic users who want oral-only glp-1 tablets from a publicly traded company. Choose Novi if you want: cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer.
Still undecided? Editor's Featured Pick
TrimRx
$149/mo · 7.8/10 · Compounded
If neither MangoRx nor Novi feels like the right fit, our featured pick across all 53 GLP-1 telehealth providers is TrimRx. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $149/mo that stays the same at every dose.
Read Full Reviews
Related comparisons
Other matchups readers comparing MangoRx or Novi tend to look at next.
- MangoRx vs MyStart Health$299/mo
- MangoRx vs Direct Meds GLP-1$297/mo
- MangoRx vs Breeze Meds$199/mo
- Novi vs DudeMeds$149/mo
- Novi vs Tonik Wellness$149/mo
- Novi vs MyStart Health$299/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.